07/30/2012 - 5:19pm

The Food and Drug Administration has approved Watson Pharmaceuticals’ Next Choice One Dose (levonorgestrel) tablets in the 1.5-mg strength.

07/30/2012 - 5:19pm

In July, the country’s largest trade group representing the drug industry released a report showing nearly 200 drugs under clinical development or Food and Drug Administration review for treating mental disorders.


07/30/2012 - 2:50pm

Stiefel, a GlaxoSmithKline company, announced the availability of Sorilux foam by prescription.

07/30/2012 - 10:16am

Drug maker Takeda Pharmaceutical has resubmitted regulatory approval applications for two drugs designed to treat diabetes, the company said.

07/27/2012 - 12:19pm

Horizon Pharma announced it has received regulatory approval from the Food and Drug Administration for one of its drugs.

07/26/2012 - 10:21am

The Senate Committee on Commerce, Science and Transportation on Wednesday released a staff report on the investigation into the gray market for pharmaceuticals — what the committee defined as "shady operators who make enormous profits by buying hard-to-find drugs and reselling them at huge markups" — specifically naming pharmacies as a primary culprit.

07/24/2012 - 4:14pm

A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).

07/24/2012 - 3:21pm

The Food and Drug Administration has approved a new drug made by Forest Labs for treating chronic obstructive pulmonary disease, the agency said.

07/24/2012 - 10:02am

An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer's disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.